Search this site:

Vol. 23, No. 1
January 2000

Editorial

Optimal Therapeutic Management of Non-Q-Wave Myocardial Infarction

C. R. Conti, M.D., M.A.C.C. 1

Special Article

Methods Used to Interpret the 12-Lead Electrocardiogram: Pattern Memorization versus the Use of Vector Concepts

J. W. Hurst, M.D. 4

Reviews

Selective Estrogen Receptor Modulators--A New Age of Estrogens in Cardiovascular Disease?

J. A. Guzzo, M.D., M.P.H. 15

Anomalies in the Dosing of Diltiazem

P. E. Pool, M.D. 18

Clinical Investigations

Dipyridamole-Induced Reversible Thallium-201 Defect in Patients with Vasospastic Angina and Nearly Normal Coronary Arteries

H. Fujita, M.D., H. Yamabe, M.D., M. Yokoyama, M.D. 24

Rest and Exercise Hemodynamics before and after Valve Replacement--A Combined Doppler/Catheter Study

U. Nellessen, M.D., G. Inselmann, M.D., J. Ludwig, M.D., R. Jahns, M.D., A. J. Capell, M.D., P. Eigel, M.D. 32

Lipid-Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long-Term Experience in a Large Group of Patients with Hypercholesterolemia

L. Ose, M.D., Ph.D., M. H. Davidson, M.D., E. A. Stein, M.D., Ph.D., J. J. P. Kastelein, M.D., R. S. Scott, M.D., D. B. Hunninghake, M.D., S. Campodonico, M.D., W. Insull, M.D., I. D. Escobar, M.D., H. G. Schrott, M.D., M. E. Stepanavage, M.S., M. Wu, M.S., A. C. Tate, M.S., M. R. Melino, Ph.D., M. Mercuri, M.D., Y. B. Mitchel, M.D., for The World Wide Expanded Dose Simvastatin Study Group  39

Incidence and Significance of Profound Hypotension during Dobutamine Stress Echocardiography

M. R. Dhond, M.D., T. B. Whitley, M.D., S. Singh, B.S.C., T. T. Nguyen, D.O., W. J. Bommer, M.D. 47

Images in Cardiology

Tricuspid Stenosis and Regurgitation: Doppler and Color Flow Echocardiography and Cardiac Catheterization Findings

J.-W. Ha, M.D., Ph.D., N. Chung, M.D., Ph.D., Y. Jang, M.D., Ph.D., S.-J. Rim, M.D., Ph.D. 51

Cardiac Hemangioma

J.-W. Ha, M.D., Ph.D., M.-H. Lee, M.D., B.-C. Chang, M.D., Ph.D., N. Chung, M.D., Ph.D., J. Kwan, M.D., S.-H. Cho, M.D., Ph.D. 53

Fungal Endocarditis of the Mitral Valve

A. Kirchgatterer, M.D., J. Auer, M.D., K. Täuber, M.D., R. Balon, M.D., B. Eber, M.D. 55

Progress in Clinical Trials

CHAMP (Combination Hemotherapy And Mortality Prevention) 56
ASAP (Azimilide Supraventricular Arrhythmia Program) 56
BEST (Beta blocker Evaluation of Survival Trial) 56
CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) 57
ELITE II (Evaluation of Losartan In The Elderly) 57
ERASE Chest Pain (Emergency Room Assessment of Sestamibi for Evaluating Chest Pain) 57
HOPE (Heart Outcomes Prevention Evaluation) 58
HBP Care (Comprehensive HBP Care in Young Urban Black Men) 58

Short Communications

Tachycardia-Dependent Right Bundle-Branch Block with Supernormal Conduction

T. Katoh, M.D., S. Kinoshita, M.D., Y. Tsujimura, M.D., Y. Sasaki, M.T., Y. Oyama, M.D. 59

Antidromic Atrioventricular Reentrant Tachycardia Mimicking Ventricular Tachycardia in the Setting of Previous Myocardial Infarction

N. Dagres, M.D., J. R. Clague, M.D., MRCP, H. Kottkamp, M.D., G. Breithardt, M.D., FESC, FACC, M. Borggrefe, M.D., FESC 63

Profiles in Cardiology

John B. Barlow: Master Clinician and Compleat Cardiologist

Tsung O. Cheng, M.D. 66

Book Review

Thrombolytic Therapy 68

©1997-2002 Foundation for Advances in Medicine and Science